Changes in lipoprotein particle number with ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidemic patients.

Journal of the American Heart Association

Volumn 2, Issue 4, 2013, Pages

  Le, Ngoc Anh ^a   Jin, Ran ^b   Tomassini, Joanne E ^b   Tershakovec, Andrew M ^b   Neff, David R ^b   Wilson, Peter W F ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; AZETIDINE DERIVATIVE; BIOLOGICAL MARKER; DELAYED RELEASE FORMULATION; DRUG COMBINATION; EZETIMIBE, SIMVASTATIN DRUG COMBINATION; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; SIMVASTATIN;

AGED; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HUMAN; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

AGED; AZETIDINES; BIOLOGICAL MARKERS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NIACIN; PARTICLE SIZE; SIMVASTATIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899592699     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.113.000037     Document Type: Article

References (0)